Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

European journal of clinical pharmacology ·Vol. 7 ·No. 1 ·1974-00-00 ·Pages 31-7

Odar-Cederlöf I, Borgå O

Abstract

暂无摘要

MeSH Terms

Adult Aged Blood Proteins/metabolism Carbon Radioisotopes Chromatography, Gas Creatinine/metabolism Female Half-Life Humans Male Mathematics Middle Aged Phenytoin/metabolism Protein Binding Serum Albumin/metabolism Time Factors Uremia/metabolism

Chemicals

Blood Proteins Carbon Radioisotopes Serum Albumin Phenytoin Creatinine

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Odar-Cederlöf I

Borgå O

References (15)

15 references, click to expand

Volume terms in pharmacokinetics.
J Pharm Sci. 1969 May;58(5):639-41 PMID: 5796463
Abnormal pharmacokinetics of phenytoin in a patient with uraemia.
Lancet. 1970 Oct 17;2(7677):831-2 PMID: 4196062
Kinetics of diphenylhydantoin disposition in man.
Chem Pharm Bull (Tokyo). 1970 Feb;18(2):405-11 PMID: 5438584
Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.
N Engl J Med. 1971 Jul 29;285(5):264-7 PMID: 4378402
Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.
Scand J Clin Lab Invest. 1972 May;29(3):281-7 PMID: 5037625
Recent myocardial infarction and the conduction system. A clinico-pathological correlation.
Br Heart J. 1972 Aug;34(8):774-80 PMID: 5070107
Treatment of arrhythmias: basic considerations.
Med Clin North Am. 1971 Mar;55(2):435-44 PMID: 4926059
Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.
Eur J Clin Pharmacol. 1971 Sep;3(4):189-93 PMID: 5151301
Effect of mode of administration on drug distribution in a two-compartment open system.
J Pharm Sci. 1969 Mar;58(3):327-31 PMID: 5782025
Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.
Res Commun Chem Pathol Pharmacol. 1972 May;3(3):455-66 PMID: 5034507
The electrophysiological properties of diphenylhydantoin sodium as compared to procaine amide in the normal and digitalis-intoxicated heart.
Circulation. 1967 Jul;36(1):108-18 PMID: 6027206
The rate of decline of diphenylhydantoin in human plasma.
Clin Pharmacol Ther. 1970 Jan-Feb;11(1):121-34 PMID: 5410894
Fatalities following intravenous use of sodium diphenylhydantoin for cardiac arrhythmias. Report of two cases.
JAMA. 1967 Apr 24;200(4):335-6 PMID: 6071476
Diphenylhydantoin metabolism in uremia.
N Engl J Med. 1971 Sep 16;285(12):648-52 PMID: 5563477
Relationship between the plasma level of diphenylhydantoin sodium and its cardiac antiarrhythmic effects.
Circulation. 1968 Aug;38(2):363-74 PMID: 5666850

Article Info

Journal

European journal of clinical pharmacology

Abbr.

Eur J Clin Pharmacol

ISSN

0031-6970

DOI

10.1007/BF00614387

Published

1974-00-00

Pages

31-7

Language

English

Region

Germany

NLM ID

1256165

Subset

External Links

PubMed source DOI: 10.1007/BF00614387 View journal details

Analysis Services

Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Contact

WeChat Official Account